Caricamento...
Ipilimumab for advanced melanoma: experience from the Spanish Expanded Access Program
Ipilimumab, a fully human, recombinant, monoclonal antibody to cytotoxic T-lymphocyte antigen 4 improves overall survival (OS) in previously treated and untreated metastatic melanoma. This retrospective analysis reports data gathered by a questionnaire on the demographics, outcomes, and toxicity of...
Salvato in:
| Pubblicato in: | Melanoma Res |
|---|---|
| Autori principali: | , , , , , , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Lippincott Williams & Wilkins
2014
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4457498/ https://ncbi.nlm.nih.gov/pubmed/25046550 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/CMR.0000000000000108 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|